We investigated the role of nitric oxide (NO) in leukocyte-endothelium interaction, blood-brain barrier (BBB) function and oxygen free-radical production in the rat pial mi crocirculation, In a closed cranial window preparation (dura removed) over the parietal cortex of pentobarbital-anesthetized Wistar rats, NO synthase (NOS) was inhibited by systemic and/or topical application of N"-nitro-L-arginine (L-NNA) un der physiological conditions and during leukotriene B4 (LTB4) activation, Circulating leukocytes were labeled by intravenous injection of rhodamine 6G, We used a confocal laser scanning microscope (CLSM) and studied leukocyte rolling and sticking in pial veins and arteries before and after NOS inhibition_ At the end of the experiments, sodium-fluorescein. was injected intravenously to test BBB integrity. Brain cortex oxygen free radical production was investigated in the cranial window preparation using lucigenin-enhanced chemiluminescence (CL). L-NNA application did not lead to significant changes in leukocyte-endothelium interaction, BBB function, and oxygen free-radical production under physiological conditions [leuko cyte-endothelium interaction: control (n = 5), L-NNA systemiNitric oxide (NO) or a related compound has been shown to play an important role in the blood tlow regu lation of various tissues, including the regulation of rest ing and stimulated cerebral blood flow (CBF) during global (i.e., with CO2) and functional activation of the cerebral cortex (for review, see Iadecola et aI., 1994a). ± 0.20, 1.19 ± 0.23, 1.21 ± 0.54; oxygen free-radical production (n = 4): CL count before L-NNA application 35 ± 17 cps, after 1 h of topical superfusion of L-NNA 38 ± 14 cps; p < 0.05]. In contrast to the results achieved under physiological conditions, a significant further increase of rolling leukocytes and BBB permeability occurred due to NOS inhibition under LTB4-activated conditions [76 ± 47% significant (p ",;; 0.01, n = 7) further increase of rollersll 00 fLm due to 60 min L-NNA ap plication following the activation period of 120 min LTB4 su perfusionJ. Our results support a modulatory role for NO in leukocyte-endothelium interaction and BBB permeability in the pial microcirculation when this interaction is increased. Key Words: Blood-brain barrier-Cranial window-Laser Doppler-Confocal microscopy-Fluorescence-Chemilum inescence.
cally (n = 5), L-NNA topically (n = 5): at baseline roliersliOO fLm: 0.76 ± 0.55, 0.64 ± 0.94, 0.44 ± 0.55 and stickers/ l 00 fLm: 0.90 ± 0.28. 0.76 ± 0.24, 0.84 ± 0.42; at 60 min rollers/IOO fLm: 1.49 ± 0.66, 1.21 ± 0.99, 0.67 ± 0.66 and stickersliOO fLm: 1.04 ± 0.20, 1.19 ± 0.23, 1.21 ± 0.54; oxygen free-radical production (n = 4): CL count before L-NNA application 35 ± 17 cps, after 1 h of topical superfusion of L-NNA 38 ± 14 cps; p < 0.05]. In contrast to the results achieved under physiological conditions, a significant further increase of rolling leukocytes and BBB permeability occurred due to NOS inhibition under LTB4-activated conditions [76 ± 47% significant (p ",;; 0.01, n = 7) further increase of rollersll 00 fLm due to 60 min L-NNA ap plication following the activation period of 120 min LTB4 su perfusionJ. Our results support a modulatory role for NO in leukocyte-endothelium interaction and BBB permeability in the pial microcirculation when this interaction is increased. Key Words: Blood-brain barrier-Cranial window-Laser Doppler-Confocal microscopy-Fluorescence-Chemilum inescence.
In addition to its vascular effects via modulation of smooth muscle function, NO may play a role in the mi crocirculation by affecting leukocyte-endothelium inter action. Impairment of endothelial NO production in mes enteric venules in vivo leads to a drastic increase in leukocyte adherence to the vascular endothelium (Kubes et aI., 199 1) possibly due to a superoxide anion radical mechanism (Gaboury et aI., 1993) . In addition, increases of neutrophil adhesion during NOS inhibition have also been observed in the heart (Ma et aI., 1993) , liver (Har brecht et aI., 1992) , and skeletal muscle (Persson et aI., 1990) . So far, the role of NO in leukocyte-endothelium interaction has only been studied in detail in the circu lation of non cerebral tissues. The brain microvascular endothelium, which forms the blood-brain barrier (BBB) differs functionally, antigenetically, and morphologically from extracerebral vascular endothelium. In addition, in the brain, NO is constitutively not only produced by the endothelium, but also by the surrounding parenchyma (neurons, astrocytes, etc.) . Data from extracerebral tis sues concerning the role of NO in leukocyte-endo thelium interaction may, therefore, not be applicable to the brain.
The aim of this study was to investigate whether NO also plays a role in leukocyte-endothelium interaction during physiological as well as leukotriene B4 (LTB4) activated conditions in the cerebral microcirculation. Leukocyte-endothelium interaction in pial vessels of the cerebral cortex of anesthetized rats were studied before and during systemic anc\Jor topical application of the irreversible nitric oxide synthase (NOS) inhibitor No)_ nitro-L-arginine (L-NNA) under physiological conditions and during topical application of the leukotactic com pound LTB4 using a cranial window preparation and confocal laser scanning microscopy (CLSM). Because the oxygen free-radical superoxide anion has been im plicated to participate in the role that NO might play in leukocyte-endothelium interaction, additional experi ments were performed to investigate oxygen free-radical production of the cerebral cortex under physiological conditions before and during topical NOS inhibition in vivo with lucigenin-enhanced chemiluminescence (CL) in the same experimental model.
MATERIALS AND METHODS

General preparation
Male Wistar rats (280-320 g), were anesthetized with pen tobarbital (Trapanal, 100 mg/kg body wt, Byk Gulden, Kon stanz, Germany), tracheotomized, and mechanically ventilated. The left femoral artery and vein were cannulated for physi ological monitoring, intravenous saline infusion (infusion rate I mlth), and application of drugs. Body temperature was moni tored and maintained at 38 ± 0.5°C using a heating pad. Sys temic arterial blood pressure (SAP) and endexpiratory Peo2 (Heyer EGM J, Bad Ems, Gennany) were monitored continu ously and blood gases measured periodically (A VL LIST, Graz, Austria). Animals were placed in a stereotactic frame and a closed cranial window was implanted over the right parietal cortex (Dirnagl et aI., 1991) . The dura mater was removed and the exposed brain continuously superfused (superfusion rate, I mlth) with artificial cerebrospinal fluid (aCSF) (composition in mM): K+, 3; Na+, 150; Ca 2 +, 1.25; Mg 2 +, 0.6; Cl-, 132: HCO,-, 24.5; glucose 3.7; urea 6 (Levasseur et al.. 1975) , which was equilibrated with a gas mixture containing (in %) °2, 6.6; CO2, 5.9; and Nz, 87.5 leading to the following gas tensions and pH: P02, 119 ± 8 mm Hg; Pe02, 34.6 ± 3.9 mm Hg: and pH 7.36 ± 0.03.
CLSM setup
For monitoring leukocytes within the pial circulation, we used a Bio-Rad MRC 600 CLSM system (Bio-Rad Microsci ence, Watford, U.K.) (for details, see Oirnagl et aI., 1992) . In brief, the CLSM was attached to a Nikon Optiphot microscope with a Zeiss water immersion objective con-ected for a cover slip with a numerical aperture of 0.75, a working distance of 1.6 mm, and x40 magnification. We used a Krypton laser (Ion Laser Technology, Salt Lake City, UT, U.S.A.) with principle lines at 488, 568, and 647 nm as light source. Confocal mi croscopy was performed through the cranial window. To visu alize leukocytes, rhodamine 6G (Sigma Chemicals) was in jected intravenously (200 J.Lg/ml in 0.9% saline, I ml as bolus injection, followed by continuous infusion at an infusion rate of I mlth). After intravenous injection of rhodamine 6G, circulat ing leukocytes (polymorphonuclear leukocytes, lymphocytes and monocytes) and platelets were labeled, whereas endothelial (ECs) and red blood cells remained unstained (Dimagl et aI., 1994; Villringer et aI., 1991) . Rhodamine 6G staining, accord ing to this protocol, does not affect leukocyte function (Lorenzi et aI., 1993; Dirnagl et aI., 1994; Villringer et aI., 1991) . Ap propriate filter sets for rhodamine 6G imaging were used. An average of seven different sites of exposed pial microvascula ture per ani mal was recorded (area, 317 x 2 I 1 J.Lm) at a frame rate of 16/s for 60 s and digital/analog converted for record ing on a video recorder (Panasonic NV-V 8000 EG, Osaka, Japan). Images were analyzed off-line from the video recording by redigitalization. The CLSM was equipped with a computer controlled x-y-z stage, permitting movement of the object with an accuracy of O. I J.Lm in every dimension. It was, therefore, possible to return exactly to each of the seven recording sites during the course of the experiment.
In vivo CL recording setup
Reactive oxygen species were detected by lucigenin enhanced CL in vivo. For a detailed description of this tech nique, see Oirnagl et al. (1995) . In brief, the animal in the stereotactic frame was housed in a dark box and covered with aluminum foil to exclude photons from sources other than CL and to prevent spontaneous ultra weak CL. The unshielded cra nial window was positioned under a reflector focused to the photon sensitive area of a cooled (-20°C) photomultiplier (Hamamatsu R943-02) with a dark count of 3 cps at -20°C. The animal within the dark box was housed in a second, larger dark box, equipped with metal shielding (Faraday cage) to exclude photons and other electromagnetic waves unrelated to brain CL from outside. To record oxygen free-radicals opti cally, brain topical superfusion of the CL enhancer lucigenin ( I 0-3 M, I mlth) was used. Lucigenin reacts with oxygen free radicals producing photons in the blue/green wavelength range. Lucigenin-induced CL is particularly sensitive to the intracel lular production of the superoxide anion radical (Faulkner and Fridovich, 1993) , regardless of the cell type within the brain. Counts of the photomultiplier were amplified and counted by a Hewlett Packard Universal counter (HP 5316 B9) connected to a PC for data recording and storage.
NOS activity determination
Immediately after experiments, tissue specimens were re moved from the cortex in situ to depth of I mm under the cranial window and frozen in liquid N2 for later analysis. The NOS assay was based on assessing the conversion of L-eHl arginine to L-l3Hl-citrulline (Bredt and Snyder, 1989) . Tissue samples of lO mg per 150 J.LI buffer were homogenized in a Potter-Elvehjem homogenizer with a Teflon pestle, four-five strokes, in ice-cold 0.05 M TRIS buffer (pH 7.4) containing I . 15 % (wt/v) KCI, I mM EDT A, 5 mM glucose, 0.1 mM D, L dithiothreitol (OTT), 200 U/ml superoxide dismutase, 2 mg/L pepstatin A, 10 mg/L trypsin inhibitor, 44 mg/l phenyl methyl sulfonyl tluoride. The homogenate was centrifuged for 10 min in a refrigerated bench microcentrifuge at 2,000 g (4°C). The protein concentration was measured at 224 and 236.5 nm using serum albumin as a standard and a detection limit of 5 J.Lg/ml. Determination of NOS activity was performed in a reaction buffer: 50 mM HEPES buffer (pH 7.4), containing 1 mM EDTA, 1.25 mM CaCL2, I mM DTT, I IJ.M flavin adenine dinucleotide, I fLM calmodulin, IS fLM 6R-tetrahydrobiopterin, I fLM L-eHl-arginine (1 fLCi final concentration). The super natant was added to obtain a final protein concentration of 15-30 fLg/ml in a reaction volume of 150 fLl. The reaction was initiated by adding the cofactor NADPH to a final concentra tion of 1 mM. Samples were incubated for 30 min at 37°C. The reaction was terminated by adding I ml of ice-cold 100 mM HEPES buffer (pH 5.5) containing 10 mM EGTA (stop buffer). The total volume (1 ml) was applied to a 0.5 ml DOWEX AG50 WX-8 column (NA + -form) that had been equilibrated with the stop buffer minus EGTA. L-[2,3-3Hl-citrulline was eluted twice with 0.5 ml stop buffer minus EGT A and the radioactivity determined by liquid scintillation counting.
NOS activity in sham-operated animals (n = 2) was assayed and used as control. Percent inhibition was calculated by com paring enzyme activity in tissue exposed to the NOS inhibitor L-NNA [applied either systemically (n = 2) or topically (n = 2) and systemically and topically in combination (n = 2)] versus controls.
Experimental paradigm (Fig. 1)
In the first two studies (I and II), leukocyte-endothelium interaction was investigated before and 30 and 60 min after L-NNA application by counting leukocytes moving slowly along the wall of pial vessels at a velocity less than that of the other blood components (rollers) or adhering to the vascular wall for> 10 s (stickers) per each 100 fLm of vessel-length during the 60-s observation period. In study I, L-NNA was applied systemically by i.v. injection of 10 mg/kg body wt. For topical application in study II, L-NNA (10-3 M) was dissolved in aCSF and continuously superfused over the cranial window.
In studies I and II, a laser-Doppler flow (LDF) probe moni tored rCBF through the closed cranial window in the area of confocal imaging. In addition to the ex vivo NO� activity de termination assay, a decrease of re.sting rCBF and appearance of vasomotion marked the effectivity of the NOS blockade in the brain cortex underlying the cranial window in all animals (Dirnagl et al. 1993a, b) .
In studies III and IV, the leukotactic compound LTB4 (7.5 x 10-9 M) was superfused over the cranial window for 3 h. Ex periments of 3 h of topical superfusion of L TB4 without L-NNA application served as controls in the LTB4-activation study (study III, LTB4). In study IV. after a 2-h LTB4 activation period, in the third hour of the experiments, L-NNA was ap plied systemically (10 mg/kg i.v.) and topically (10-3 M) dur ing further LTB4 superfusion (study IV, LTB4 + L-NNA). The effect of the combination of systemical and topical L-NNA application without previous activation due to L TB4 superfu sion was tested in another two animals. To study BBB integrity, at the end of each experiment in studies I-IV, sodium-fluorescein (MW 376, Sigma Chemicals) was injected intravenously (2 mg/100 g body wt) (Leakage of this low molecular weight dye is a sensitive marker for BBB disruption). Extravasation of sodium-fluorescein was investi gated in vivo using CLSM (Dirnagl et aI., 1994) . At 10 min after the bolus injection, leakage of sodium-tluorescein into the extravascular space was graded qualitatively as no extravascu lar fluorescence (grade 0), slight appearance of fluorescence outside the pial vessels along the vessel wall (grade I), slight level of fluorescence not only along pial vessels but also throughout the brain surface (grade 2), and high fluorescence on brain surface (grade 3).
Because the role of NO in leukocyte-endothelium interaction has been implicated as being closely related to the oxygen free-radical superoxide, in study V, lucigenin-enhanced CL was recorded at baseline and during topical application of L NNA. Superfusion of lucigenin had already been performed 60 min before start of the baseline measurement of oxygen free radicals to obtain a stable photon count; 60 min is the time needed for lucigenin to diffuse into the extracellular space and into the cells of the cortex. After 60 min of baseline recording, L-NNA was superfused topically for I h Lucigenin-enhanced CL was recorded continuously throughout the whole experi ment.
Data analysis
Numbers of rollers or stickers per 100 fLm vessel length before and after 30 and 60 min ofL-NNA application, in control and study groups I and II; and before and after 2 h of L TB4 superfusion, and after 3 h LTB4-with and without L-NNA superfusion in the third hour in study groups IV and III were compared using repeated-measures analysis of variance (ANOV A). Changes in numbers of rollers or stickers per 100 fLm vessel length after 3 h in study groups III (LTB4 alone) and IV (LTB4 + L-NNA) (in %; values at 2 h of L TB4 activation = 100% in each group) were compared using Student's unpaired t-test. Lucigenin-enhanced CL before and after 1 h of NOS blockade was compared using Student's paired t-test; p-values < 0.05 were considered statistically significant. All data are presented as means ± standard deviation (SO).
RESULTS
Physiological variables
During experiments, all physiological parameters were within normal ranges, except for SAP, which increased significantly after systemic L-NNA application in studies I and IV. Physiological variables are summarized in Table 1 .
NOS activity determination
NOS activity in sham-operated animals was assayed and set at 100% as control. Whereas systemic application of the NOS inhibitor L-NNA reduced the NOS activity only to 54%, topically applied L-NNA and systemic and topical combined application led to reductions of NOS activity by 89 and 90%, respectively. These results are in accordance with other data from the literature: nitro-L arginine-the active metabolite of other NOS inhibi tors, e.g., nitro-L-arginine methyl ester (L-NAME) application according to this protocol has been shown in numerous studies to reduce brain NOS activity by -50% when applied systemically, and by >90% during topical application (Traystman et aI., 1995; Irikura et aI., 1994; Iadecola et aI., 1994b) .
The NOS activity assay as described here does not distinguish between constitutive and inducible NOS. In the ischemic brain, expression of inducible NOS mRNA starts as early as 12 h after onset of ischemia (Iadecola et aI., 1995) , suggesting that the L TB4-activation period in studies III and IV is too short to cause expression of inducible NOS during the course of the experiment. Therefore, the main NOS activity measured in our ex periments is expected to originate from the constitutive NOS in neurons, astrocytes, and endothelial cells in the brain. Values are means ± SD.
CLSM
The mean length of the pial vascular network investi gated per site per animal was 277 ± 52 f.Lm in study I (systemical L-NNA application), 29 1 ± 46 f.Lm in study II (topical L-NNA application), 294 ± 33 f.Lm in controls, 150 ± 11 f.Lm in study III (L TB 4), and 192 ± 76 f.Lm in study IV (L TB4 + L-NNA). Diameters of the vessels investigated ranged from 20 to 100 f.Lm in the venous system and from 15 to 90 f.Lm in the arterial system.
There was only a very slight and nonsignificant in crease in the numbers of rolling or sticking leukocytes during the 60-min observation times in studies I and II (Table 2 ) and during the combination of systemic and topical L-NNA application (n = 2) (data not shown) in the pial venous system. This slight, nonsignificant in- crease was also observed in the control group during the observation time. Therefore, no significant difference in leukocyte behavior was detected between animals of the control group and of studies I and II groups with either systemic or topical, or systemic and topical application of the NOS inhibitor L-NNA. Table 2 summarizes these data.
In studies III and IV, leukocyte rolling was signifi cantly increased during continuous superfusion of a low concentration of the leukoattractant compound LTB4. In contrast to the physiological state in studies I and II, NOS inhibition due to systemic and topical application of the NOS inhibitor following 2 h of LTB4 activation (study IV) led to a significant increase in the numbers of rolling leukocytes in the pial venous system (Table 2,   TABLE 2 . Leukocyte-endothelium interactions in pial veins at seven cortical sites per animal Figs. 2 and 3) compared to LTB4 administration alone (3 h in study III). Due to high variations in the absolute numbers of increased rolling leukocytes during LTB4 superfusion, there was only a slight, but not significant, difference in the absolute values seen after the third hour of the observation period between studies III and IV. Nevertheless, a significant difference (p :%=0.0 I) exists when comparing the % increase of rolling leukocytes in the third hour (second hour = 100%) between studies III and IV. This discrepancy in the significance between absolute and percentage values can be explained by high variations in the degree of activation of leukocyte endothelium interaction due to LTB4 application from animal to animal. Regardless of the absolute degree of activation of leukocyte-endothelium interaction in each individual animal, the level reached after the second hour of the observation period did not increase further during the third hour of superfusion of LTB4 alone throughout all experiments in study III.
In previous experiments in our laboratory (Dirnagl et aI., 1994) , it was shown that, under physiological condi tions, there is no change in leukocyte-endothelium inter action during a 240-min observation period (a prolonged control group). This information is provided in addition to the 60-min control group for comparison with studies III and IV.
A typical example of the imaging of leukocytes within a pial vein with CLSM before and after 2 h of LTB4 application is shown in Fig. 4 . L TB4 application alone (study III) did not lead to a significant change in the numbers of sticking leukocytes within the pial circulation of the cerebral cortex. LTB4 superfusion followed by L-NNA application (study IV) led to a small but significant increase of sticking leuko cytes compared to baseline recordings (see Table 2 ).
In pial arteries. no significant rolling or sticking of leukocytes was observed at any time point in any experi mental group. NOS inhibition alone did not affect BBB integrity dur ing systemic and/or topical L-NNA application (no sta tistical significant difference to grade 0). In addition, no BBB dysfunction was observed in the control group. L TB4 application alone led to only slight leakage of sodium-fluorescein into the extravascular space in all animals of study III (grade 1). This slightly enhanced BBB permeability was significantly increased due to NOS inhibition following LTB4 superfusion (study IV) (grade 2 in all animals).
Lucigenin-enhanced CL
Topical application of the NOS inhibitor L-NNA in study V did not change the photon count in the CL ex-
Effect of L-NNA on numbers of rolling leu kocytes per 100 I-Im (in 60 s) of pial veins. In the physiological state, there is no significant difference between baseline (bl) conditions and the situation during NOS inhibition (control group and studies I and II, n = 5 in each group). After activation of the leukocyte-endothelium interaction with L TB4 (7.5 X 10-9 M) for 120 min (study IV, n = 7), however, a significant increase in numbers of rolling leukocytes occurred during L-NNA application. *, significantly different from baseline conditions, p,,; 0.01; **, sig nificantly different from 120 min L TB4 activation conditions, p,,; 0.01.
periments. The photon count before L-NNA application was 35 ± 17 cps, and after I h of topical superfusion of L-NNA, it was 38 ± 14 cps. Inhalation of 100% O2 in creased the photon count by 20 ± 8 cps. After animals were killed (i.v. injecti � n of KC1), the photon count de creased to 8 ± 7 cps. The dark count of the system was 3 ± I cps. A typical tracing is shown in Fig. 5 .
DISCUSSION
In the present study, we found that neither systemic nor topical application of the NOS inhibitor L-NNA led to significant changes in leukocyte-endothelium interac tion in the pial circulation of the brain cortex of barbi-
Effect of NOS inhibition on numbers of leukocytes per 100 I-Im of pial veins rolling along the vessel wall (60 s) under L TB4-activated condi tions. Whereas after 120 min of L TB4 superfusion (7.5 x 10-9 M) a plateau was reached and another 60 min of L TB4 superfusion alone did not further increase the numbers of rolling leuko cytes (study III, n = 6), LTB4, + L-NNA (applied topically and systemically) significantly enhanced leukocyte endothelium interaction (study IV, n = 7). *, significantly differ�nt from 120 min of L TB4 superfusion, p,,; 0.01. ing a pial venule during baseline con ditions. Note that there is no rolling or sticking leukocyte in this area. One leukocyte, seen at the upper rim of the vessel, is moving at blood stream velocity. Scale bar is 20 I-lm. B: Same optical section as in A after 2 h of topical L TB4 application. Leukocytes in this section, which have an elon gated or almost round shape, are roil ing along the vessel wall at a velocity less than that of the blood stream (for discrimination of rolling or sticking leukocytes, this section was continu ously imaged for 1 min). Scale bar is 20 I -lm.
turate-anesthetized rats under physiological conditions, and that BBB integrity was not affected by NOS inhibi tion. Topical application of low concentrations of the leukoattractant compound LTB4 induced slight, but sig nificant, rolling of leukocytes along the endothelium. Following this mild activation of leukocyte-endothelium interaction, NOS inhibition further significantly acti vated leukocyte-endothelium interaction and increased BBB permeability. In the following discussion, we will compare our results to studies performed mainly in non cerebral tissues and try to explain the different results found in different microvascular beds. In several non cerebral tissues (e.g., heart, skeletal muscle, liver), an important role for NO in the regulation of leukocyte-endothelium interaction has been demon strated (Persson et aI., 1990; Ma et aI., 1993; Harbrecht et aI., 1992) . Most of the studies investigating the in crease in leukocyte-endothelium interaction during NOS inhibition were performed in intestinal and mesenteric tissue. In the gastrointestinal tract, systemic as well as topical NOS inhibition increased leukocyte-endothelium interaction in postcapillary venules, leading to adhesion and emigration of leukocytes (Kubes et aI., 1993; Kubes et aI., 1991) . The role of NO in the regulation of vascular perme ability is discussed controversely. In some studies, inhi bition of NO production induced albumin and horserad ish peroxidase leakage in venules of mesenteric and in testinal tissue (Kanwar et aI., 1994; Kurose et aI., 1993; Kubes and Granger, 1992) as well as cerebral arterioles (Prado et aI., 1992) . In contrast, other investigators showed that NOS inhibition did not affect basal levels of vascular permeability but reduced augmented permeabil ity in various tissues, including brain (Haberl et aI., 1994; Hughes et aI., 1990; Mayhan, 1993) .
Mechanisms of NO effects on leukocyte-endothelium interaction
The mechanisms by which NO modulates microvas cular endothelium function are not sufficiently resolved. Because superoxide anion (02-) can be inactivated by NO, it has been suggested that NO suppression may en hance O2-levels in the tissue, thus leading to functional changes in microvascular endothelium, such as leuko cyte-endothelium interaction and vascular permeability (Gaboury et aI., 1993) . Tn addition, mast cell degranula tion, which releases pro-inflammatory agents that cause leukocyte adhesion to endothelium, can be induced by superoxide. These findings suggest that basal levels of NO in vivo may continuously inactivate the proadhesive molecule superoxide.
Besides this scavenging effect of NO on superoxide, other mechanisms of enhanced leukocyte-endothelium interaction are discussed. Recently, it was shown that NO suppression-induced enhancement of endothelial adhesiveness may be mediated by a direct intracellular increase in oxidative stress in arteriolar and venular en dothelial cells, and in mast cells in the mesenteric mi crocirculation, that is followed by venular leukocyte ad hesion (Suematsu et aI., 1994) .
Another mechanism of NO-associated antiinflamma tory properties was shown recently (Peng et aI., 1995) . Those authors found that NO inhibits the activation of the transcription factor NF-KB (which itself, when acti vated, leads to the expression of proinflammatory me diators) through induction and stabilization of the NF-KB inhibitor IKBa, even under basal conditions in a cell culture system.
NO and leukocyte-endothelium interaction in the brain: comparison to other tissues In our cranial window preparation studies on the brain cortex, very low baseline levels of rolling and sticking leukocytes were detected and no increase in leukocyte endothelium interaction occurred due to NOS inhibition. In addition' , we found no increase in superoxide produc tion of the cerebral cortex using lucigenin-enhanced CL during topical L-NNA application. It is unlikely that this negative finding was due to a sensitivity problem of CL. In every experiment, oxygen inhalation led to a signifi cant increase in the photon count. This increase was caused by a slight increase in superoxide production due to hyperoxia. Much larger increases in the photon count have been shown during reoxygenation after cerebral hypoxia or ischemia (Dimagl et aI., 1995) .
Whereas, in the mesentery in the intra-abdominal situs under physiological conditions, neither rolling nor stick ing of leukocytes was present, leukocyte-endothelium in teraction increased rapidly after exteriorization in experi mental studies and remained high over a long period (Fiebig et aI., 1991) . Therefore, Fiebig et al. suggested that inflammation is present in experimental mesentery preparations, and this results in relatively high levels of rolling or sticking leukocytes at the beginning of the experiments. In addition, Ma et aI. (1993) have shown, that NOS inhibition in myocardial ischemia promotes neutrophil adherence only after reperfusion, in which free radical production is enhanced.
To mimic these experimental conditions in other tis sues, in which leukocyte-endothelium interaction was in crease before NOS inhibition (i.e., by the experimental preparation), we produced a slight activation of leuko cyte-endothelium interaction by topical LTB4 applica tion. This induces a weak respiratory burst in neutrophils . In addition, leukocytes have been shown to produce superoxide anion radicals due to LTB4 application in vitro (Maghni et a!., 1991; Murohara et a!., 1995) . In a previous video microscopy study, it was shown that cerebral superfusion of LTB4 induces an in crease in leukocyte-endothelium interaction in the same range as in our study, without an increase in BBB per meability (Schiirer et a!., 1994) .
Under these LTB4-activated conditions, we found a slight but significant increase of leukocyte-endothelium interaction and BBB permeability after NOS inhibition, findings that are in accordance with those of other stud ies in noncerebral tissues.
Besides these methodological issues, other tissue specific mechanisms may also be involved in the differ ences in the role of NO in leukocyte-endothelium inter action and vascular permeability in the brain compared to noncerebral tissues: (a) smaller lymphocyte binding capacities of cerebral endothelial cells compared to en dothelial cells of other tissues (Male et a!., 1990) ; (b) tight junctions of high electrical resistance between ce rebral endothelial cells, presenting an effective barrier even to ions. Peripheral endothelial cells are either fe nestrated or have tight junctions of low resistance be tween the cells (Rowland et a!., 1991) ; (c) low mast cell content of the cerebral cortex; mast cells in the brain are found particularly in the leptomeninges, thalamus, and hypothalamus (Theoharides, 1990) . In the brain, station ary interstitial immunocytes are mainly represented by microglial cells. During activation of interstitial immu nocytes, pro inflammatory agents such as superoxide an ion are released. In the normal brain, microglial cells are not activated, and lack phagocytic and secretory activi ties (Giulian, 1992) .
In conclusion, our data support a modulatory role for NO in leukocyte-endothelium interaction and BBB in tegrity in the pial microcirculation of the brain when this interaction is increased. This may be important for patho physiological states of the brain, e.g., cerebral ischemia, during which induction of leukocyte-endothelium inter action occurs (Garcia et a!., 1994) and NO levels in the brain tissue increase (Malinski et aI., 1993) . However, our data imply that basal NO production is not involved in modulating leukocyte-endothelium interaction. This latter finding is in contrast to results of a number of studies of the role of NO in leukocyte-endothelium in teraction in noncerebral tissues. It remains open whether this discrepancy is due to methodological factors, par ticularly the degree of activation of leukocytes at the beginning of NOS inhibition, or to differences in the endothelium and/or surrounding tissues, resulting in dif ferent levels of superoxide in the resting state.
